Estradiol-17 beta and progesterone increase ovine uterine suppressor cell activity.
We evaluated the regulation of ovine uterine (UT) suppressor cell activity by progesterone (P4), estradiol-17 beta (E2), and P4 + E2 in ovariectomized (OVX) ewes. Following 14 d of steroid injections, endometrial cells (designated as UT cells) were recovered postmortem, and unfractionated and fractionated cells were assessed for suppression of autologous phytohemagglutinin (PHA)-treated peripheral blood lymphocytes (PBL). Supernatants from cultured UT cells were also assessed for suppressor activity. In other experiments, UT cells recovered from nontreated OVX ewes were cocultured with PHA-treated PBL and varying concentrations (1 x 10(-11) to 1 x 10(-5) M) of each steroid preparation. Supernatants from separate cultures that contained UT cells and steroids were evaluated for suppressor activity. Uterine cells from control and steroid-treated ewes suppressed proliferative responses of PHA-treated PBL; however, suppressor activity of UT cells was greater (P < .05) for E2-treated than for control and P4-treated ewes. Uterine suppressor cells from steroid-treated ewes sedimented in Percoll within a density range of 1.002 to 1.056 g/mL. Uterine cells from all ewes released suppressor factor(s) into the culture medium; however, the activity of the supernatant from the cultured cells was not increased for the steroid-treated ewes. For cocultures that contained steroids and cultures that contained supernatant, suppressor activity of the UT cells was increased by specific concentrations of each steroid preparation. These findings demonstrate that reproductive steroids augment ovine UT suppressor cell activity.
Segerson
E C
EC
Department of Animal Science, North Carolina A&T State University, Greensboro 27411, USA.
Li
H
H
Talbott
C W
CW
D000818:Animals; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D018920:Coculture Techniques / Q000662:veterinary; D003470:Culture Media / Q000737:chemistry; D004247:DNA / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004717:Endometrium / Q000166:cytology; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D010052:Ovariectomy / Q000662:veterinary; D010835:Phytohemagglutinins / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology*; D012044:Regression Analysis; D012756:Sheep / Q000378:metabolism / Q000502:physiology*; D013491:Suppressor Factors, Immunologic / Q000032:analysis / Q000378:metabolism; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D013936:Thymidine / Q000378:metabolism; D014599:Uterus / Q000166:cytology* / Q000187:drug effects* / Q000502:physiology
D003470:Culture Media; D010835:Phytohemagglutinins; D013491:Suppressor Factors, Immunologic; D011374:Progesterone; D004958:Estradiol; D004247:DNA; D013936:Thymidine